International – COVID-19 Vaccine Tracker

On 11 March, the World Health Organization classified the COVID-19 outbreak as a pandemic. The disease has reached nearly every country, infecting hundreds of thousands of people and killing thousands.

Currently, there are no FDA-approved therapies or vaccines for SARS-CoV-2, the virus that causes COVID-19. The National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) is leading the funding of federal research and response to COVID-19, while some companies in the US are choosing to fund their own COVID-19 research. Internationally, the UK Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) have called for targeted efforts to develop therapies against COVID-19.

Experts estimate it could take between 12-18 months to develop a vaccine ready for market, which assumes the process from conception to market availability goes smoothly. This tracker lists the major vaccine candidates in development for prevention of COVID-19

This tracker will be updated weekly. If you notice an issue with this data or wish to submit an update, please email Focus at news@raps.org.

Phase 1 vaccine candidates…